title: Development of a physiologically based pharmacokinetic model for chlorobenzene in F-344 rats.
abstract: A physiologically based pharmacokinetic (PBPK) model to describe the absorption, distribution, metabolism, and elimination of chlorobenzene in rats was developed. Partition coefficients were experimentally determined in rat tissues and blood samples using an in vitro vial equilibration technique. These solubility ratios were in agreement with previous reports. The in vivo metabolism of chlorobenzene was evaluated using groups of three F344 male rats exposed to initial chlorobenzene concentrations ranging from 82 to 6750 ppm in a closed, recirculating gas uptake system. An optimal fit of the family of uptake curves was obtained by adjusting Michaelis-Menten metabolic constants, K(m) (affinity) and Vmax (capacity), using the PBPK model. At the highest chamber concentration, the uptake curve could not be modeled without the addition of a first-order (Kfo) metabolic pathway. Pretreatment with pyrazole, an inhibitor of oxidative microsomal metabolism, had no impact on the slope of the uptake curve. The completed PBPK model was evaluated against real-time exhaled breath data collected from rats receiving either an intraperitoneal (i.p.) injection or oral gavage dose of chlorobenzene in corn oil. Exhaled breath profiles were evaluated and absorption rates were determined. Development of the chlorobenzene PBPK model in rats is the first step toward future extrapolations to apply to humans.
authors.affiliation: Biological Sciences Division, Pacific Northwest National Laboratory, 902 Battelle Blvd., Mail Stop P7-59, Richland, WA 99352, USA. karla.thrall@pnl.gov
authors.forename: Karla D
authors.initials: KD
authors.lastname: Thrall
authors.forename: Angela D
authors.initials: AD
authors.lastname: Woodstock
authors.forename: Melissa R
authors.initials: MR
authors.lastname: Kania
mesh_terms: D000042:Absorption; D000273:Adipose Tissue / Q000378:metabolism; D000280:Administration, Inhalation; D000284:Administration, Oral; D000818:Animals; D002722:Chlorobenzenes / Q000008:administration & dosage / Q000493:pharmacokinetics*; D004781:Environmental Exposure; D007274:Injections, Intraperitoneal; D008099:Liver / Q000378:metabolism; D008297:Male; D023421:Models, Animal; D018482:Muscle, Skeletal / Q000378:metabolism; D011659:Pulmonary Gas Exchange; D051381:Rats / Q000097:blood / Q000378:metabolism; D011916:Rats, Inbred F344 / Q000097:blood / Q000378:metabolism; D012997:Solvents / Q000008:administration & dosage / Q000493:pharmacokinetics*; D014018:Tissue Distribution
chemical_list: D002722:Chlorobenzenes; D012997:Solvents; C031294:chlorobenzene